Betaseron

Interferon beta is commonly used as therapeutic in the first line of therapy for multiple sclerosis. However, depending on the… (More)

Multiple sclerosis is a chronic autoimmune disease of the central nervous system for which a number of disease-modifying… (More)

The approved interferon beta-1b (Betaseron/Betaferon) dose is 250 microg (8 MIU) administered subcutaneously (sc) every other day… (More)

An open-label extension study of the phase III trial of intramuscular interferon beta-1a (IFNbeta-1a-Avonex) was conducted to… (More)

Protein- and peptide-based disease-modifying agents for multiple sclerosis (MS), including interferon beta (IFNbeta) and… (More)

The aim of this 1 week study was to compare the biologic effects induced by Betaseron and AVONEX using their approved dose, route… (More)

Production of T helper 1 and T helper 2 cytokines was investigated in peripheral blood mononuclear cells (PBMCs) from multiple… (More)

A new method for purifying human interferon-beta SER17 from E. coli-derived inclusion bodies has been developed. This procedure… (More)

Betaseron is a new medication that decreases the frequency and severity of exacerbations in persons with relapsing-remitting MS… (More)

Betaseron (beta ser17-interferon) was administered to 19 patients (17 evaluable) with advanced melanoma by two schedules… (More)